Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

This phase I trial studies the side effects of 68GA-PSMA-11 PET imaging in patients with prostate cancer that has come back (recurrent). Gallium (68Ga) is a radiotracer that binds to a molecule

  • 2 views
  • 20 Feb, 2021
  • 1 location
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer

To evaluate the potential usefulness of 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions, efficacy assessment and

  • 0 views
  • 11 Apr, 2021
  • 1 location
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

The goal of this research is to examine the ability of Gallium-68 (68Ga) Prostate-Specific Membrane Antigen-11 (PSMA-11) positron emission tomography/computed tomography (PET/CT) to detect sites of recurrent prostate cancer in patients with biochemical recurrence previously treated with radical prostatectomy (RP) or external beam radiation (EBRT) and to assess treatment response …

  • 0 views
  • 02 Apr, 2021
  • 1 location
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Metastatic Castration-Resistant Prostate Cancer

This trial studies the effect of androgen receptor signaling inhibitors on 68Ga-PSMA-11 PET/CT imaging in patients with castration-resistant prostate cancer that has spread to other places in

metastatic castration-resistant prostate cancer
abiraterone
testosterone level
androgens
gallium ga 68-labeled psma-11
  • 0 views
  • 03 Mar, 2021
  • 1 location
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer.

biopsy of prostate
gallium ga 68-labeled psma-11
68ga-psma-11
  • 0 views
  • 24 Jan, 2021
  • 1 location
68 Ga-PSMA for High Risk Prostate Cancer

This is a prospective, single-center, open-label pilot study of 68GA-PSMA-11 given at a single time prior to PET/CT imaging in men with localized high risk prostate cancer or biochemical

  • 0 views
  • 10 Feb, 2021
  • 1 location
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

This is a pilot study to investigate the evaluate to use of a drug/radiopharmaceutical called Gallium-68 PSMA-11 (68Ga-PSMA-11) for use in PET/MRI evaluation of hepatocellular carcinoma

liver transplant
pet scan
  • 0 views
  • 26 Jan, 2021
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer

This is a phase II clinical trial study to show how well the 68Ga-PSMA-11 (ProstaMedix) PET-CT scan works in detecting tumor location and size in patients with suspected or confirmed prostate

prostate specific antigen
68ga-psma-11
gallium ga 68-labeled psma-11
ct scan
brachytherapy
  • 245 views
  • 25 Jan, 2021
  • 3 locations
PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer

The overall objective of this Early Phase Clinical Trial is to begin defining the accuracy of 68Ga-PSMA-11 for detecting the location and size of clinically significant prostate cancer lesions

biopsy of prostate
68ga-psma-11
gallium ga 68-labeled psma-11
pet/ct scan
multiparametric magnetic resonance imaging
  • 5 views
  • 26 Jan, 2021
  • 4 locations
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

interested to investigate another new imaging technique called PSMA PET/CT. Participants will be invited to undergo a second PET/CT scan, with the PSMA tracer (68Ga-PSMA-11). This is not required but just an

pancreatic cancers
colon cancer
cancer, ovarian
breast cancer
primary tumor
  • 5 views
  • 14 Apr, 2021
  • 2 locations